Brussels, 18/04/2002 (Agence Europe) - The European Parliament has begun examination of the proposals (two directives and one regulation) put forward by the European Commission aimed at reviewing European pharmaceutical legislation. First discussions have shown there is wide convergence of views between MEPs on the essential elements of the reform, except concerning the creation of pilot projects allowing the industry to directly inform the public on medicines for three illnesses: AIDS,...